AAAAAA

   
Results: 1-8 |
Results: 8
Clinical outcome after front-line intensive sequential chemotherapy (ISC) in patients with aggressive non-Hodgkin's lymphoma and high-risk international prognostic index (IPI 3): Final analysis of survival in two consecutiveISC trials
Authors: Bouabdallah, R Stoppa, AM Coso, D Bardou, VJ Blaise, D Chabannon, C Gastaut, JA Maraninchi, D
Citation: R. Bouabdallah et al., Clinical outcome after front-line intensive sequential chemotherapy (ISC) in patients with aggressive non-Hodgkin's lymphoma and high-risk international prognostic index (IPI 3): Final analysis of survival in two consecutiveISC trials, ANN ONCOL, 12(4), 2001, pp. 513-517
True histiocytic lymphoma following B-acute lymphoblastic leukaemia: case report with evidence for a common clonal origin in both neoplasms
Authors: Bouabdallah, R Abena, P Chetaille, B Aurran-Schleinitz, T Sainty, D Dubus, P Arnoulet, C Coso, D Xerri, L Gastaut, JA
Citation: R. Bouabdallah et al., True histiocytic lymphoma following B-acute lymphoblastic leukaemia: case report with evidence for a common clonal origin in both neoplasms, BR J HAEM, 113(4), 2001, pp. 1047-1050
Chronic lymphocytic leukemia and Hodgkin's disease. Clinicopathologic study of three cases with good prognosis
Authors: Serratrice-de Roux, C Coso, D Bouabdallah, R Serratrice, J Disdier, P Weiller, PJ
Citation: C. Serratrice-de Roux et al., Chronic lymphocytic leukemia and Hodgkin's disease. Clinicopathologic study of three cases with good prognosis, HAEMATOLOG, 85(8), 2000, pp. 878-879
Role of high-dose therapy and initial response in survival of poor-risk patients with aggressive non-Hodgkin's lymphoma: a retrospective series on 126 patients from a single center
Authors: Bouabdallah, R Coso, D Costello, R Bardou, VJ Blaise, D Xerri, L Sainty, D Maraninchi, D Gastaut, JA
Citation: R. Bouabdallah et al., Role of high-dose therapy and initial response in survival of poor-risk patients with aggressive non-Hodgkin's lymphoma: a retrospective series on 126 patients from a single center, BONE MAR TR, 25(1), 2000, pp. 35-40
Safely and efficacy of splenic irradiation in the treatment of patients with idiopathic myelofibrosis: a report on 15 patients
Authors: Bouabdallah, R Coso, D Gonzague-Casabianca, L Alzieu, C Resbeut, M Gastaut, JA
Citation: R. Bouabdallah et al., Safely and efficacy of splenic irradiation in the treatment of patients with idiopathic myelofibrosis: a report on 15 patients, LEUK RES, 24(6), 2000, pp. 491-495
Acute myeloid leukemia and myelodysplasia in patients with chronic lymphocytic leukemia receiving fludarabine as initial therapy
Authors: Coso, D Costello, R Cohen-Valensi, R Sainty, D Nezri, M Gastaut, JA Bouabdallah, R
Citation: D. Coso et al., Acute myeloid leukemia and myelodysplasia in patients with chronic lymphocytic leukemia receiving fludarabine as initial therapy, ANN ONCOL, 10(3), 1999, pp. 362-363
Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high-intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin's lymphoma: an oligocentric report on 42 patients
Authors: Bouabdallah, R Stoppa, AM Rossi, JF Lepeu, G Coso, D Xerri, L Ladaique, P Chabannon, C Blaise, D Bardou, VJ Alzieu, C Gastaut, JA Maraninchi, D
Citation: R. Bouabdallah et al., Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high-intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin's lymphoma: an oligocentric report on 42 patients, LEUKEMIA, 13(6), 1999, pp. 950-956
A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patients
Authors: Bouabdallah, R Lefrere, F Rose, C Chaibi, P Harousseau, JL Vernant, JP Castaigne, S Bauduer, F Zini, JM Coso, D Varet, B Robert, J Fenaux, P
Citation: R. Bouabdallah et al., A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patients, LEUKEMIA, 13(10), 1999, pp. 1491-1496
Risultati: 1-8 |